Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Orth

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
Biomedical Engineering Online|September 3, 2014
Impact of the control for corrupted diffusion tensor imaging data in comparisons at the group level: an application in Huntington diseaseHans-Peter Müller, Jan Kassubek, Georg Grön, et al.
Journal of Huntington'S Disease|October 8, 2015
Neuropsychiatry and White Matter Microstructure in Huntington's DiseaseSarah Gregory, Rachael I Scahill, Kiran K Seunarine, et al.
Neuroendocrinology|April 6, 2025
Upregulation of SSTR2 expression and radioligand binding of [18F]SiTATE in neuroendocrine tumour cells with combined inhibition of class I HDACs and LSD1Christoph J Auernhammer, Kathrin Zitzmann, Simon Lindner, et al.
Frontiers in Oncology|April 5, 2021
Inhibition of HSP90 as a Strategy to Radiosensitize Glioblastoma: Targeting the DNA Damage Response and BeyondMichael Orth, Valerie Albrecht, Karin Seidl, et al.
European Journal of Human Genetics : EJHG|August 24, 2017
Haplotype-based stratification of Huntington's diseaseMichael J Chao, Tammy Gillis, Ranjit S Atwal, et al.
Cell Death & Disease|December 9, 2021
Nucleolar stress controls mutant Huntington toxicity and monitors Huntington's disease progressionAynur Sönmez, Rasem Mustafa, Salome T Ryll, et al.
Oncotarget|June 4, 2016
A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancerLinda Kinzel, Anne Ernst, Michael Orth, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 25, 2011
What is the impact of education on Huntington's disease?Jose Luis López-Sendón, Ana Royuela, Patricia Trigo, et al.
Cell Death & Disease|December 16, 2021
Early senescence and production of senescence-associated cytokines are major determinants of radioresistance in head-and-neck squamous cell carcinomaUlrike Schoetz, Diana Klein, Julia Hess, et al.
Journal of Huntington'S Disease|June 28, 2021
Association Analysis of Chromosome X to Identify Genetic Modifiers of Huntington's DiseaseEun Pyo Hong, Michael J Chao, Thomas Massey, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Biomedical Engineering Online|September 3, 2014
Impact of the control for corrupted diffusion tensor imaging data in comparisons at the group level: an application in Huntington diseaseHans-Peter Müller, Jan Kassubek, Georg Grön, et al.
Journal of Huntington'S Disease|October 8, 2015
Neuropsychiatry and White Matter Microstructure in Huntington's DiseaseSarah Gregory, Rachael I Scahill, Kiran K Seunarine, et al.
Neuroendocrinology|April 6, 2025
Upregulation of SSTR2 expression and radioligand binding of [18F]SiTATE in neuroendocrine tumour cells with combined inhibition of class I HDACs and LSD1Christoph J Auernhammer, Kathrin Zitzmann, Simon Lindner, et al.
Frontiers in Oncology|April 5, 2021
Inhibition of HSP90 as a Strategy to Radiosensitize Glioblastoma: Targeting the DNA Damage Response and BeyondMichael Orth, Valerie Albrecht, Karin Seidl, et al.
European Journal of Human Genetics : EJHG|August 24, 2017
Haplotype-based stratification of Huntington's diseaseMichael J Chao, Tammy Gillis, Ranjit S Atwal, et al.
Cell Death & Disease|December 9, 2021
Nucleolar stress controls mutant Huntington toxicity and monitors Huntington's disease progressionAynur Sönmez, Rasem Mustafa, Salome T Ryll, et al.
Oncotarget|June 4, 2016
A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancerLinda Kinzel, Anne Ernst, Michael Orth, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 25, 2011
What is the impact of education on Huntington's disease?Jose Luis López-Sendón, Ana Royuela, Patricia Trigo, et al.
Cell Death & Disease|December 16, 2021
Early senescence and production of senescence-associated cytokines are major determinants of radioresistance in head-and-neck squamous cell carcinomaUlrike Schoetz, Diana Klein, Julia Hess, et al.
Journal of Huntington'S Disease|June 28, 2021
Association Analysis of Chromosome X to Identify Genetic Modifiers of Huntington's DiseaseEun Pyo Hong, Michael J Chao, Thomas Massey, et al.
Pageof 15